Roche says studies show its drugs help breast cancer

	Tweet

New data shows that three drugs made by Roche Holding AG help patients with breast cancer live longer or remain disease-free for longer, the Swiss drugmaker said Wednesday.

Roche, the world’s largest maker of cancer drugs, is presenting new data at the San Antonio Breast Cancer Symposium which show that its Herceptin (trastuzumab), Xeloda (capecitabine) and Avastin (bevacizumab) drugs can help patients with early or advanced breast cancer live longer.

Roche said it would present data from a phase III study that showed that women with locally advanced breast cancer had a significantly greater chance of living disease-free 3years after treatment if they took Herceptin prior to surgery along with standard chemotherapy.

An independent study in Finland and Sweden indicates that chemotherapy pill Xeloda, already proven in advanced breast cancer, might also reduce the recurrence of early breast cancer, the company said.

Roche will also present numerous studies on Avastin, including one from the largest ever safety study in a real-life setting, which shows the drug can give breast cancer patients an average of almost 10 months without their disease getting worse.

Separately, Roche also said it was presenting long-term phase III data at the annual meeting of the American Society of Hematology that confirms the positive impact of its MabThera therapy for patients in remission with recurrent/resistant Non-Hodgkin’s lymphoma.

It said the data showed that those receiving MabThera lived almost 2.5 years longer without their disease progressing than those not receiving the treatment.

ZURICH (Reuters)

RELATED STORIES:
Researchers develop standard of care for breast cancer survivors with lymphedema   Unsuspected protein determines resistance to breast cancer treatment   Breast MRI spots other cancers, may alter treatment plan   Drop in U.S. mammography rate worries cancer experts   ‘Bridge’ Protein Spurs Deadliest Stages of Breast Cancer   Computer-Aided Detection Improves Early Breast Cancer Detection   Porter Adventist Hospital Breast Program Approved by NAPB   Pregnancy drug doubles risk of breast cancer   Walnuts May Prevent Breast Cancer   Hispanic Women and Breast Cancer: An Understudied Group   Scientists discover powerful biomarker panel for the early detection of breast cancer   Antidepressant doesn’t raise breast cancer risk   Racial disparities seen in male breast cancer survival   Contrast agent puts new light on diagnosing breast cancer   New Breast Cancer Treatment Shows Promise in Early Application   A new breast cancer susceptibility gene   Adding radiation decreases breast cancer recurrence   Community health worker interventions improve rates of US mammography screening   Is soy linked to breast cancer?   New guidelines emphasize use of breast MRI to supplement standard imaging   MRI “Best” for Looking at Breast Cancer and More   FISH Technology Preferred for Choosing HER-2-Positive Breast Cancer Treatments

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]